RxDoctor Payments Data

Romuald Warakomski, DO

Internal Medicine · Flossmoor, ILNPI 1427153618

Payments from drug & device makers

$345in general payments, 2019–2025

Across 23 payments — averaging $14.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$132
  • AbbVie$46
  • Regeneron Healthcare Solutions, Inc.$22
  • Eyevance Pharmaceuticals LLC$21
  • Hikma Pharmaceuticals USA$21
  • Daiichi Sankyo Inc.$18
  • plus $85 from 6 others

What the payments were for

  • Food & beverage$31792%
  • Education$278%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$345 in reported general payments places this provider in the 60th percentile of 5,182 internal medicine providers in Illinois.

See all internal medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$134,131
Medicare patients
248
Services billed
1,721

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide65$100,100
EliquisApixaban62$51,867
XareltoRivaroxaban45$43,336
FarxigaDapagliflozin Propanediol38$31,510
JardianceEmpagliflozin35$31,278
Trelegy ElliptaFluticasone/Umeclidin/Vilanter37$23,586
JanuviaSitagliptin Phosphate14$21,921
EntrestoSacubitril/Valsartan13$19,236
Tresiba Flextouch U-100Insulin Degludec19$17,675
RybelsusSemaglutide16$15,320
MyrbetriqMirabegron39$14,298
Repatha SureclickEvolocumab12$6,331
LinzessLinaclotide11$6,164
Rivastigmine15$3,262
Metoprolol Succinate148$2,955

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$12$43,33645 claims
GSKTrelegy Ellipta$13$23,58637 claims
AbbVieLinzess, Synthroid$46$7,08524 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 5,182 internal medicine providers in Illinois.

Other internal medicine in Flossmoor

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →